Investor Relations

Carvana Honored Among NAFA’s 2024 Best Commercial Fleets at Annual Institute & Expo

Retrieved on: 
Thursday, April 25, 2024
Automotive, Online Retail, Women, Public Relations, Investor Relations, Communications, Men, Other Automotive, General Automotive, Retail, Performance & Special Interest, Consumer, Travel, Fleet management, Multimedia, Organization

Carvana (NYSE: CVNA), an industry pioneer for buying and selling used cars online, was recognized by the NAFA Fleet Management Association (NAFA) at its annual Institute & Expo (I&E) as a top Commercial Fleet for 2024 in the Americas.

Key Points: 
  • Carvana (NYSE: CVNA), an industry pioneer for buying and selling used cars online, was recognized by the NAFA Fleet Management Association (NAFA) at its annual Institute & Expo (I&E) as a top Commercial Fleet for 2024 in the Americas.
  • View the full release here: https://www.businesswire.com/news/home/20240425455544/en/
    Carvana claims third spot among NAFA’S 2024 Best Commercial Fleets at Annual Institute & Expo.
  • (Photo: Business Wire)
    NAFA is the fleet industry’s largest membership association, with organizations across the public and commercial sectors.
  • NAFA’s selection of Carvana as the third leading Commercial Fleet after a rigorous evaluation process underscores Carvana’s dedication to operational excellence, innovative logistics solutions, and providing customer-centric service.

Intel Reports First-Quarter 2024 Financial Results

Retrieved on: 
Thursday, April 25, 2024
Technology, Communications, Semiconductor, Public Relations, Investor Relations, Open Platform, Organization, GAAP, Open platform, NEX, Ecosystem, Amazon Web Services, Supermicro, AI, H100, Wipro, Electricity, Ultra, RAG, Water, Direct connect, Red Hat, Sierra Forest, Mobile, Microsoft, Intel, NVIDIA, Dell Technologies, GPU, Enterprise, SAP, Mobile World Congress

Intel expects to exceed its prior forecast of 40 million AI PCs by the end of 2024.

Key Points: 
  • Intel expects to exceed its prior forecast of 40 million AI PCs by the end of 2024.
  • Intel also announced new Intel Gaudi accelerator customers and partners, including NAVER, Dell Technologies, Bosch, Supermicro and many others.
  • Intel continues to drive customer adoption of Intel 18A, with a major U.S. aerospace and defense customer committing to Intel 18A, bringing Intel Foundry's external customer commitments on Intel 18A to six.
  • Intel unveiled its process technology roadmap beyond its five-nodes-in-four-years process goal, adding Intel 14A to its leading-edge node lineup following Intel 18A and announcing several specialized node evolutions for Intel 3, Intel 18A and Intel 14A to enable customers to develop and deliver products tailored to their specific needs.

Expensify to Announce Q1 Results

Retrieved on: 
Thursday, April 25, 2024
Data Management, Consumer Electronics, Online Retail, Technology, Public Relations, Investor Relations, Communications, Apps, Applications, Retail, Software, Internet, Mobile, Wireless, Head

Expensify, Inc. (Nasdaq: EXFY), a payments superapp that helps individuals and businesses around the world simplify the way they manage money across expenses, corporate cards and bills, today announced that the company’s Q1 financial results will be released after market close on Thursday, May 9th, 2024.

Key Points: 
  • Expensify, Inc. (Nasdaq: EXFY), a payments superapp that helps individuals and businesses around the world simplify the way they manage money across expenses, corporate cards and bills, today announced that the company’s Q1 financial results will be released after market close on Thursday, May 9th, 2024.
  • Expensify will host a call to discuss its Q1 results on Thursday, May, 9th 2024 at 2pm PT / 5pm ET.
  • The link to the call will be available that day on the company’s Investor Relations website at investors.expensify.com .
  • To get started using Expensify or to learn more, head over to use.expensify.com .

ENTENTE Network Founder and CEO Virginia Amann Wins the Silver Stevie® for Communications, Investor Relations, PR Executive of the Year

Retrieved on: 
Thursday, April 25, 2024
Science, Other Science, Other Communications, Public Relations, Investor Relations, Health, Media, Communications, Other Health, Stevie Awards, PR, Communication, Silver, COVID-19, Organization, Growth

ENTENTE Network (“ENTENTE”) Founder and CEO Virginia Amann was named winner of the Silver Stevie® Award in the Communications, Investor Relations, or PR Executive of the Year category today in the 22nd Annual American Business Awards®.

Key Points: 
  • ENTENTE Network (“ENTENTE”) Founder and CEO Virginia Amann was named winner of the Silver Stevie® Award in the Communications, Investor Relations, or PR Executive of the Year category today in the 22nd Annual American Business Awards®.
  • Judges also noted her success in enhancing client visibility through transformative branding initiatives, large scale integrated campaigns and media relations.
  • "I am very pleased and honored to receive this recognition, which reflects the collective efforts and dedication of our remarkable team at ENTENTE," said Amann.
  • “Our ethos is to prioritize innovation, excellence and opportunity every day.”
    More than 300 professionals worldwide participated in the judging process to select this year’s Stevie Award winners.

Vantage Data Centers Expands EMEA Portfolio with First Dublin Campus Featuring Next-Generation Energy Solution

Retrieved on: 
Wednesday, April 24, 2024
Engineering, Data Management, Environment, Technology, Other Construction & Property, Manufacturing, Mobile, Wireless, Commercial Building & Real Estate, Construction & Property, Building Systems, Public Relations, Investor Relations, Architecture, Other Energy, Communications, Security, Utilities, Alternative Energy, Energy, Telecommunications, Software, Internet, Hardware, Vantage, Safety, Partnership, Ervia, Grange Castle, Employment, Carbon, Cloud computing, HVO, Public policy, Pressure, PUE, Data, Multimedia, Power usage effectiveness, Renewable energy

Vantage Data Centers, a leading global provider of hyperscale data center campuses, today announced its entrance into the Irish market with the development of a multi-phase data center campus ( DUB1 ).

Key Points: 
  • Vantage Data Centers, a leading global provider of hyperscale data center campuses, today announced its entrance into the Irish market with the development of a multi-phase data center campus ( DUB1 ).
  • Upon completion, DUB1 will mark Vantage’s 14th EMEA campus in a growing regional portfolio that spans seven countries.
  • View the full release here: https://www.businesswire.com/news/home/20240424930079/en/
    Vantage Data Centers’ flagship Dublin campus will include 52MW of IT capacity to enable next-generation applications and digital transformation.
  • “The South Dublin Chamber warmly welcomes the confidence shown in our area through the €1 billion investment by Vantage Data Centers,” said Peter Byrne, CEO, South Dublin Chamber.

HighField Biopharmaceuticals Announces Two Abstracts Accepted for the 2024 ASCO Annual Meeting

Retrieved on: 
Wednesday, April 24, 2024
Biotechnology, Health, General Health, Public Relations, Investor Relations, Pharmaceutical, Oncology, Communications, Other Science, Research, Science, Clinical Trials, Cancer, Prostate, HER2, Doxorubicin, Abstract, Stomach, Breast, Tumor microenvironment, Uterus, ATRA, ASCO, Therapy, Patient, Society, Lung

HighField Biopharmaceuticals, a clinical stage immuno-oncology company using lipid-based therapeutics to treat cancer, announced today that two HighField abstracts have been accepted with one poster presentation at the American Society of Clinical Oncology (ASCO) annual meeting May 31-June 4, 2024, in Chicago, IL.

Key Points: 
  • HighField Biopharmaceuticals, a clinical stage immuno-oncology company using lipid-based therapeutics to treat cancer, announced today that two HighField abstracts have been accepted with one poster presentation at the American Society of Clinical Oncology (ASCO) annual meeting May 31-June 4, 2024, in Chicago, IL.
  • “The ASCO meeting is an important opportunity to share our unique lipid-based technology with other clinical investigators,” said Yuhong Xu, Ph.D., Founder and CEO of HighField.
  • HFK1 is a drug encapsulated immunoliposome containing doxorubicin for patients with advanced refractory solid tumors having HER2 low and HER2+ expression.
  • HF1K16 is a drug encapsulated immune modulating liposome containing all-trans retinoic acid (ATRA) for patients with recurrent and refractory glioma.

Arrowhead Pharmaceuticals Initiates Phase 1/2a Study of ARO-CFB for Treatment of Complement Mediated Kidney Disease

Retrieved on: 
Wednesday, April 24, 2024
Science, Research, Pharmaceutical, Public Relations, Investor Relations, General Health, Health, Communications, Clinical Trials, Kidney disease, IgA nephropathy, RNA interference, Arrowhead, Kidney, CFB, RNA, Patient, Liver, System, Translational medicine, Discovery, MBA, Complement factor B, Vaccine

Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) announced today that it has dosed the first subjects in a Phase 1/2a clinical trial ( NCT06209177 ) of ARO-CFB, the company’s investigational RNA interference (RNAi) therapeutic, in up to 66 healthy volunteers and patients with complement mediated kidney disease.

Key Points: 
  • Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) announced today that it has dosed the first subjects in a Phase 1/2a clinical trial ( NCT06209177 ) of ARO-CFB, the company’s investigational RNA interference (RNAi) therapeutic, in up to 66 healthy volunteers and patients with complement mediated kidney disease.
  • James Hamilton, M.D., MBA, Chief of Discovery and Translational Medicine at Arrowhead, said: “In preclinical studies, ARO-CFB achieved deep and durable reductions in liver production of complement factor B, which is involved in alternative complement pathway activation and associated with pathogenesis of diseases involving complement activation.
  • ARO-CFB is our second clinical program designed to address diseases associated with activation of the complement pathway, the first being ARO-C3, our Phase 1 program targeting complement component 3.
  • ARO-CFB is being developed as a potential treatment for complement mediated kidney diseases such as immunoglobulin A nephropathy (IgAN), which is the most common glomerular disease worldwide and carries a high lifetime risk of progression to end-stage renal disease.

WPP First Quarter Trading Update

Retrieved on: 
Thursday, April 25, 2024
Professional Services, Marketing, Advertising, Communications, Finance, Public Relations, Investor Relations, Cloud, VML, The Coca-Cola Company, NHS, Pandemic, Daiichi Sankyo, Risk, WPP plc, Capital market, Google Cloud, Transplant, Epidemic, WPP, Medicine, Terrorism, FX, AstraZeneca, Breast cancer, Knowledge, Attack, Outline of health sciences, Super Bowl, Uncertainty, HCM, Workforce, Generative, Blood, Gemini, Travel, Artificial intelligence, Perrigo, Gold, Creativity, FY, Ogilvy, Disclosure, LFL, Synthetic media, Failure, WARC, Growth

During the quarter we continued to invest in WPP Open, our intelligent marketing operating system powered by AI, as part of our annual investment of £250m in AI, data and tech.

Key Points: 
  • During the quarter we continued to invest in WPP Open, our intelligent marketing operating system powered by AI, as part of our annual investment of £250m in AI, data and tech.
  • WPP was proud to be recognised by the NVIDIA Partner Network as the Industry Innovation Partner of the Year in EMEA.
  • During the quarter, WPP topped the WARC Media 100 for the seventh year running and topped the WARC Creative 100 for the second consecutive year.
  • Proportion of WPP revenue less pass-through costs in Q1 2024; table made up of clients representing 77% of WPP total revenue less pass-through costs.

CPI Card Group Inc. to Release First Quarter Results on May 7, 2024

Retrieved on: 
Friday, April 26, 2024
Software, Public Relations, Investor Relations, Communications, Consumer Electronics, Technology, Online Retail, Digital Cash Management, Digital Assets, Retail, PMTS, Telephone, CPI, Webcast

CPI Card Group Inc. (Nasdaq: PMTS) (“CPI Card Group”), a payments technology company and leading provider of credit, debit, and prepaid card and digital solutions, including Software-as-a-Service-based instant issuance, today announced it will host a webcast and conference call on Tuesday, May 7, 2024 at 9:00 a.m. Eastern Time (ET) to discuss its first quarter financial results.

Key Points: 
  • CPI Card Group Inc. (Nasdaq: PMTS) (“CPI Card Group”), a payments technology company and leading provider of credit, debit, and prepaid card and digital solutions, including Software-as-a-Service-based instant issuance, today announced it will host a webcast and conference call on Tuesday, May 7, 2024 at 9:00 a.m. Eastern Time (ET) to discuss its first quarter financial results.
  • CPI Card Group’s financial results for the first quarter will be released before the markets open on May 7, 2024.
  • The press release and a slide presentation to accompany the earnings conference call will be available on the CPI Card Group investor website: CPI Card Group - Investor Relations ( https://investor.cpicardgroup.com ).
  • A replay of the conference call will be available until May 21, 2024 at:
    A webcast replay of the conference call will also be available on CPI Card Group Inc.’s Investor Relations web site: https://investor.cpicardgroup.com